← Back to Clinical Trials
Recruiting NCT06893406

Cervical Myelopathy in Hip Fracture Patients

Trial Parameters

Condition Cervical Myelopathy
Sponsor Indiana University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 75
Sex ALL
Min Age 50 Years
Max Age N/A
Start Date 2025-05-01
Completion 2026-03-20
Interventions
Cervical MRIHistory & Physical Exam

Brief Summary

Recent evidence has demonstrated a high rate of undiagnosed cervical myelopathy in patients presenting with hip fractures from a ground level fall. Identification and treatment of cervical myelopathy can help prevent falls and future fragility fractures. The purpose of this study is to screen ground level fall hip fracture patients for cervical myelopathy using a history, physical exam, and then offer an MRI if indicated.

Eligibility Criteria

Inclusion Criteria: * Patient admitted to Eskenazi, Methodist, or IU North hospital for a hip fracture (femoral neck, intertrochanteric, subtrochanteric, or pertrochanteric fracture) that was caused by a ground level fall. Exclusion Criteria: * Neurologic or cognitive disorder explaining the fall (dementia, Parkinson's disease, delirium, etc.) * Syncopal fall or fall caused by stroke or a heart condition

Related Trials